Negative predictive value of SPECT with I123 ioflupane in movement disorders (reply);Valor predictivo negativo de la SPECT con ioflupano-I-123 en los trastornos del movimiento (réplica)

Revista Espanola de Medicina Nuclear

Volumn 28, Issue 5, 2009, Pages 267-268

  Serrano Vicente, J ^a   Garcia Bernardo L ^a   Duran Barquero C ^a   Constantino Silva, A ^b   Infante de la Torre, J R ^a   Dominguez Grande M L ^a   Rayo Madrid, J I ^a   Sanchez Sanchez R ^a   Duran Herrera C ^b  

^a Servicio de Medicina Nuclear   (Spain)

^b Servicio de Neurología   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IOFLUPANE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

DIAGNOSTIC IMAGING; HUMAN; LETTER; MOTOR DYSFUNCTION; NEUROLOGY; NUCLEAR MEDICINE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

HUMANS; IODINE RADIOISOTOPES; MOVEMENT DISORDERS; NORTROPANES; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70249090695     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/j.remn.2009.05.005     Document Type: Letter

References (4)

1. Benamer H.T., Patterson J., Grosset D.G., Booij J., De Bruin K., Van Royen E., et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group. Mov Disord 15 (2000) 503-510
2. Parkinson Study Group. A multicentre assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Neurology 55 (2000) 1540-1547
3. Benamer H.T., Oertel W.H., Patterson J., Hadley D.M., Pogarell O., Hoffken H., et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3-month observations. Mov Disord 18 (2003) 977-984
4. Marshall V.L., Patterson J., Hadley D.M., Grosset K.A., and Grosset D.G. Two-year follow up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Comm 27 (2006) 933-937